Dermatology · Minneapolis, MN
NPI
1720594500
Since 2017
Specialty
Dermatology
Code 207N00000X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
909 Fulton St SE Fl 3
Minneapolis, MN, 55455
Phone (612) 625-6118
Groups this clinician bills Medicare through
Medicare paid, 2024
$39K
5,165 services
Medicare patients, 2024
139
Average age 66
Drug cost, 2024
$787K
769 prescriptions
Company payments, 2025
$8,502
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul L Bigliardi was code 95044 (test - miscellaneous), 3,036 times for 56 patients. In total Paul L Bigliardi billed 5,165 services in 36 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-12-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95044 Test - Miscellaneous | Office | 3,036 | 56 | $3.79 | $12K |
| 95004 Test - Miscellaneous | Office | 1,328 | 63 | $2.57 | $3,412 |
| 95024 Test - Miscellaneous | Office | 180 | 35 | $6.19 | $1,113 |
| 95018 Test - Miscellaneous | Office | 172 | 46 | $13.67 | $2,352 |
| J2540 Injection, penicillin g potassium, up to 600,000 units | Office | 109 | 28 | $0.67 | $72.9 |
| 99214 Office E&M - Established | Office | 91 | 66 | $85.81 | $7,808 |
| 99213 Office E&M - Established | Office | 48 | 38 | $66.58 | $3,196 |
| J0290 Injection, ampicillin sodium, 500 mg | Office | 28 | 27 | $0.65 | $18.22 |
| 99204 Office E&M - New | Office | 24 | 24 | $122.89 | $2,949 |
| 99215 Office E&M - Established | Office | 22 | 21 | $133.29 | $2,932 |
| 99203 Office E&M - New | Office | 21 | 21 | $71.43 | $1,500 |
| J0690 Injection, cefazolin sodium, 500 mg | Office | 12 | 11 | $0.59 | $7.03 |
By year: 2022 $38K for 4,151 services; 2023 $42K for 5,583 services; 2024 $39K for 5,165 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paul L Bigliardi prescribed most often to Medicare patients was Mometasone Furoate, with 129 prescriptions and refills. In total Paul L Bigliardi wrote 769 Medicare prescriptions that cost $787K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mometasone Furoate Generic | 129 | 155 | 53 | $4,847 |
| Montelukast Sodium Generic | 56 | 97 | 13 | $579 |
| Dupixent Syringe Dupilumab | 52 | 52 | Under 11 | $193K |
| Adbry Tralokinumab-Ldrm | 49 | 49 | Under 11 | $187K |
| Prednisone Generic | 49 | 55 | 34 | $95.34 |
| Tacrolimus Generic | 48 | 69 | 29 | $7,342 |
| Hydroxyzine Hcl Generic | 44 | 52 | 17 | $263 |
| Dupixent Pen Dupilumab | 41 | 41 | Under 11 | $162K |
| Azelastine Hcl Generic | 35 | 64 | 14 | $592 |
| Xolair Omalizumab | 29 | 29 | Under 11 | $53K |
| Triamcinolone Acetonide Generic | 27 | 29 | 22 | $145 |
| Opzelura Ruxolitinib Phosphate | 27 | 27 | Under 11 | $55K |
| Levocetirizine Dihydrochloride Generic | 22 | 30 | Under 11 | $184 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 21 | 21 | Under 11 | $3,750 |
| Ketoconazole Generic | 16 | 23 | Under 11 | $211 |
Brand drugs: 274 claims; generic drugs: 495 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul L Bigliardi $8,502 ($8,502 in general payments such as food, travel and fees) from 5 companies. The largest payer was Galderma Laboratories, L.P. with $5,785.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.